• Treatment for Drug-Resistant Non-Small Cell Lung Cancer (No. T4-1944)

    Non-Small Cell Lung Cancer (NSCLC) is a very common type of cancer, and despite currently available therapies, is one of the deadliest due to the emergence of drug resistance, which results in tumor recurrence. ... Read more
    Extension Service Yosef Yarden

    Yosef Yarden

    Faculty of Biology

  • New Antiviral Drugs from Bacterial Natural Products (No. T4-1934)

    The increasing incidence of viral infections across the globe is driving the demand for antiviral drugs. Prof. Rotem Sorek and his team identified a new family of bacterial enzymes that produce various nucleotide analogs with antiviral properties (Bernheim, Nature 2021). ... Read more
    Full Professor Rotem Sorek

    Rotem Sorek

    Faculty of Biochemistry

  • Higher Efficiency of CRISPR Gene Editing Using Chimeric Cas9 (No. T4-1930)

    CRISPR-Cas9 is a powerful tool for genome editing, widely used for basic research and the development of treatments for genetic diseases. However, its efficiency is currently limited. ... Read more
    Emeritus Yosef Shaul

    Yosef Shaul

    Faculty of Biochemistry

  • Modulating Protein Degradation through COP9 Signalosome regulation (No. T4-1923)

    A potentially therapeutic method to interfere with CSNAP activity, a key negative regulator of protein degradation. ... Read more
    Associate Professor Michal Sharon

    Michal Sharon

    Faculty of Biochemistry

  • Protein Based Treatment for Duchene Muscular Dystrophy and Cancer (No. T4-1913)

    Duchenne muscular dystrophy (DMD) is a disease that affects approximately 1 in 3,500 boys with a life expectancy of ~26 years. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

  • Preventing Biofilm Formation by Enzyme Inhibitors (No. T4-1893)

    Biofilm is a complex colony of bacteria, which are attached together by extracellular polymeric substance. This setting provides the bacteria protection against environmental factors, improves their surface attachment, and plays a major role in resistance to treatment. ... Read more
    Senior Scientist ILANA Kolodkin-Gal

    ILANA Kolodkin-Gal


  • Universal CAR-Ts for Treating Cancer (No. T4-1884)

    Chimeric Antigen Receptor T-Cells (CAR-Ts) are one of the revolutionary technologies of the twenty-first century, invented by Prof. Zelig Eshhar at the Weizmann Institute of Science. ... Read more
    Emeritus Zelig Eshhar

    Zelig Eshhar

    Faculty of Biology

  • A Platform for Identifying Specific Autophagy Inhibitors for Cancer (No. T4-1883)

    Autophagy plays a vital role in the survival of many solid tumors, often leading to drug resistance in chemotherapy and targeted treatments. Prof. ... Read more
    Prof Adi Kimchi

    Adi Kimchi

    Faculty of Biochemistry

  • Targeting Novel Regulator for Improved Hematopoietic Stem Cells Generation (No. T4-1874)

    A potential method of generating hematopoietic stem cells for transplantation by inhibiting CD74. ... Read more
    Full Professor Idit Shachar

    Idit Shachar

    Faculty of Biology

  • Microbiome-Based Prediction, Diagnosis, and Treatment of Relapsing Obesity (No. T4-1805)

    A novel method for analyzing the likelihood of weight regain following a weight loss program and maintaining target body weight, based on gut microbiome analysis. ... Read more
    Associate Professor Eran Elinav

    Eran Elinav

    Faculty of Biology

    Full Professor Eran Segal

    Eran Segal

    Faculty of Mathematics and Computer Science



Subscribe to Pharmaceuticals